|
Market Closed -
Nasdaq
00:00:00 30/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 41.84 USD | +1.85% |
|
-0.55% | -15.81% |
| 10-30 | Supernus Pharmaceuticals, Inc., Q3 2026 Earnings Call, Oct 29, 2026 | |
| 10-30 | Earnings Flash (SUPN) Supernus Pharmaceuticals Posts Q3 EPS $0.35, vs. FactSet Est of $0.08 Loss | MT |
Stock exchange
Nasdaq
SUPN 41.84 $
+1.85%
78.88M
$
Quotes 5-day view: Supernus Pharmaceuticals, Inc.
Delayed Quote Nasdaq
| 23/10/2026 | 26/10/2026 | 27/10/2026 | 28/10/2026 | 29/10/2026 | |
|---|---|---|---|---|---|
| Last | $40.70 | $40.77 | $40.96 | $41.08 | $41.84 |
| Volume | 1,159,336 | 930,903 | 1,075,468 | 1,099,364 | 1,885,193 |
| Change | -3.26% | +0.17% | +0.47% | +0.29% | +1.85% |
| Opening | $41.68 | $40.72 | $40.57 | $40.46 | $44.24 |
| High | $41.95 | $40.87 | $41.20 | $41.18 | $44.31 |
| Low | $39.96 | $39.58 | $39.87 | $39.67 | $40.75 |
Performance
| 1 day | +1.85% | ||
| 1 week | -0.55% | ||
| Current month | -2.79% | ||
| 1 month | -4.84% | ||
| 3 months | -10.16% | ||
| 6 months | -13.82% | ||
| Current year | -15.81% | ||
| 1 year | -24.86% | ||
| 3 years | +77.59% | ||
| 5 years | +40.17% | ||
| 10 years | +103.11% |
Volumes
marketsDaily volume
1,885,193
Estimated daily volume
1,885,193
Avg. Volume 20 sessions
1,050,615
Daily volume ratio
1.79
Avg. Volume 20 sessions USD
43,957,731.6
Record volume 1
11,208,680
Record volume 2
6,737,648
Record volume 3
6,644,855
Capital turnover ratio
0.02
Float rotation
0.02
Basic data
Market Cap (USD)
2,432,034,223
Net sales (USD)
718,952,000
Number of employees
778
Sales / Employee (USD)
924,103
Free-Float
95.68%
Free-Float capitalization (USD)
2,330,803,849
Average Daily Capital Traded
1.81%
Indicators
Moving average 5 days
41.07
Moving average 20 days
41.42
Moving average 50 days
42.75
Moving average 100 days
44.63
Price spread / (MMA5)
-1.84%
Price spread / (MMA20)
-1.01%
Price spread / (MMA50)
+2.16%
Price spread / (MMA100)
+6.66%
STIM
RSI 9 days
48.22
RSI 14 days
46.49
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.85% | -0.55% | -24.86% | +77.59% | 2.43B | |
| +6.63% | +5.13% | +68.86% | +145.20% | 1,224B | |
| +1.53% | +2.84% | +47.48% | +89.01% | 662B | |
| +1.68% | +1.96% | +29.16% | +109.31% | 514B | |
| +0.65% | +2.45% | +54.26% | +68.96% | 388B | |
| +3.83% | -0.62% | +69.01% | +42.32% | 361B | |
| +0.94% | +2.65% | +34.31% | +57.95% | 302B | |
| +3.34% | +0.55% | +3.92% | +28.92% | 271B | |
| +1.97% | +3.01% | +57.91% | +76.14% | 249B | |
| +4.03% | +5.36% | +39.76% | +116.14% | 205B | |
| Average | +2.22% | +2.28% | +37.98% | +81.15% | 417.93B | |
| Weighted average by Cap. | +2.20% | +3.04% | +50.40% | +96.48% |
Historical Quotes: Supernus Pharmaceuticals, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
417fa63536d690aafeb.crKofPtgpAhEPK5DsPvhE--J6fp2idJGB22IR69OtPk.GdvETrIiyj4JRfZ344qFS5bA3rUi270MYAnqK-0t0c1K3903jCP8JQ1Q-w
| Date | Price | Volume | Total |
|---|---|---|---|
| 00:00:00 | 41.84 | 98,395 | 1,478,526 |
| 23:59:59 | 41.72 | 100 | 1,380,131 |
| 23:59:59 | 41.74 | 100 | 1,380,031 |
| 23:59:59 | 41.74 | 100 | 1,379,931 |
| 23:59:59 | 41.76 | 100 | 1,379,831 |
| 23:59:57 | 41.85 | 100 | 1,379,731 |
| 23:59:56 | 41.85 | 100 | 1,379,631 |
| 23:59:56 | 41.85 | 100 | 1,379,531 |
| 23:59:56 | 41.83 | 100 | 1,379,431 |
| 23:59:56 | 41.83 | 100 | 1,379,331 |
Price Extremes
| 1 week | 39.58 |  | 44.31 |
| 1 month | 37.54 | | 44.31 |
| Current year | 37.54 | | 59.68 |
| 1 year | 37.54 | | 59.68 |
| 3 years | 23.04 | | 59.68 |
| 5 years | 21.99 | | 59.68 |
| 10 years | 13.12 | | 61.25 |
Monthly variations
Annual variations
| 2026 | -15.81% | ||
| 2025 | +37.44% | ||
| 2024 | +24.95% | ||
| 2023 | -18.87% | ||
| 2022 | +22.33% | ||
| 2021 | +15.90% | ||
| 2020 | +6.07% | ||
| 2019 | -28.60% | ||
| 2018 | -16.64% | ||
| 2017 | +57.82% | ||
| 2016 | +87.87% | ||
| 2015 | +61.93% | ||
| 2014 | +10.08% | ||
| 2013 | +5.16% | ||
| 2012 | +33.52% |
- Stock Market
- Stocks
- SUPN Stock
- Quotes Supernus Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
